User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis : findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.

  1. Ginzler, N Engl J Med, 353, 2219 (2005)
  2. Grootscholten, Arthritis Rheum, 56, 924 (2007)
  3. Bezerra, Arthritis Rheum, 52, 3073 (2005)
  4. Ng, Ann Rheum Dis, 66, 1259 (2007)
  5. Gordon, Rheumatology (Oxford), 47, 334 (2008)
  6. Griffiths, Arthritis Rheum, 54, S789 (2006)
  7. Fortin, Arthritis Rheum, 59, 1796 (2008)
  8. Tam, Lupus, 13, 601 (2004)
  9. Wang, Lupus, 17, 638 (2008)
  10. Tam, Ann Rheum Dis, 65, 417 (2006)
  11. Crosbie, Cochrane Database Syst Rev, 17 (2007)
  12. Chatham, Arthritis Rheum, 58, S573 (2008)
  13. Wallace DJ, Lisse J, Stohl W, McKay J, Boling E, Merrill JT, et al. Belimumab (Bmab), a fully human monoclonal antibody to B-lymphocyte stimulator (Blys), shows bioactivity and reduces systemic lupus erythematosus disease activity. Proceedings of the Annual European Congress of Rheumatology (EULAR); 2006 June 21–24; Amsterdam, The Netherlands.
  14. Furie R, Lisse J, Merrill JT, Petri M, Ginzler E, Aranow C, et al. Multiple SLE disease activity measures in a multi-center phase 2 SLE trial demonstrate belimumab (fully human monoclonal antibody to B-lymphocyte stimulator [Blys]) improves or stabilizes SLE activity. Proceedings of the Annual European Congress of Rheumatology (EULAR); 2006 June 21–24; Amsterdam, The Netherlands.
  15. Mok, Scand J Rheumatol, 36, 329 (2007)
  16. Pisoni, J Rheumatol, 32, 1047 (2005)
  17. Gordon, Ann Rheum Dis, 68, 470 (2009)
  18. Hay, Q J Med, 86, 447 (1993)
  19. Isenberg, Lupus, 9, 651 (2000)
  20. Sinclair, Lupus, 16, 972 (2007)
  21. Appel, J Am Soc Nephrol, 20, 1103 (2009)
  22. Hochberg, Arthritis Rheum, 40, 1725 (1997)
  23. Weening, J Am Soc Nephrol, 15, 241 (2004)
  24. Austin, N Engl J Med, 314, 614 (1986)
  25. Brunner, Arthritis Rheum, 42, 1354 (1999)
  26. Ward, J Rheumatol, 27, 664 (2000)
  27. Isenberg, Rheumatology (Oxford), 44, 902 (2005)
  28. Yee, Arthritis Rheum, 54, 3300 (2006)
  29. Petri, Lupus, 8, 685 (1999)
  30. Gladman, Arthritis Rheum, 39, 363 (1996)
  31. Gladman, Arthritis Rheum, 40, 809 (1997)
  32. Alba, Lupus, 12, 633 (2003)
  33. Mak, Lupus, 14, 856 (2005)
  34. Mok, Ann Rheum Dis, 65, 971 (2006)
Bibliographic reference Ginzler, Ellen M ; Wofsy, David ; Isenberg, David ; Gordon, Caroline ; Lisk, Laura ; et. al. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis : findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.. In: Arthritis and rheumatism, Vol. 62, no. 1, p. 211-221 (2010)
Permanent URL http://hdl.handle.net/2078.1/105312